Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance

AJ Narayan, LA Downey, B Manning… - … & Biobehavioral Reviews, 2022 - Elsevier
Cannabidiol's (CBD) safety profile and broad action has made it a popular treatment option
for anxiety and co-occurring sleep disturbance. However, its efficacy in healthy and clinical …

Factors that impact the pharmacokinetic and pharmacodynamic effects of cannabis: a review of human laboratory studies

CA Zamarripa, R Vandrey, TR Spindle - Current Addiction Reports, 2022 - Springer
Abstract Purpose of Review With cannabis legalization expanding throughout the world, an
unprecedented number of people now have access to legal cannabis. This expanded …

Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial

J Vela, L Dreyer, KK Petersen, L Arendt-Nielsen… - Pain, 2022 - journals.lww.com
Cannabidiol (CBD) is increasingly used as analgesic medication although the recent
International Association for the Study of Pain Presidential Task Force on cannabis and …

Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: implications for patients and practitioners

OS Miller, EJ Elder Jr, KJ Jones, BE Gidal - Epilepsy & Behavior, 2022 - Elsevier
Purpose Cannabidiol products remains largely unregulated in the US. Unlike the Rx
formulation of CBD [Epidiolex R], little information is available regarding labeling accuracy …

Statement on safety of cannabidiol as a novel food: data gaps and uncertainties

EFSA Panel on Nutrition, Novel Foods and Food … - EFSA …, 2022 - Wiley Online Library
Abstract The European Commission has determined that cannabidiol (CBD) can be
considered as a novel food (NF), and currently, 19 applications are under assessment at …

Cannabidiol for the treatment of autism spectrum disorder: hope or hype?

JFC Pedrazzi, FR Ferreira, D Silva-Amaral… - …, 2022 - Springer
Rationale Autism spectrum disorder (ASD) is defined as a group of neurodevelopmental
disorders whose symptoms include impaired communication and social interaction …

Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool

CMB Kwee, JMA van Gerven… - Journal of …, 2022 - journals.sagepub.com
Background: Preclinical research suggests that cannabidiol (CBD) may have therapeutic
potential in pathological anxiety. Dosing guidelines to inform future human studies are …

[HTML][HTML] Why do marijuana and synthetic cannabimimetics induce acute myocardial infarction in healthy young people?

J Weresa, A Pędzińska-Betiuk, K Mińczuk… - Cells, 2022 - mdpi.com
The use of cannabis preparations has steadily increased. Although cannabis was
traditionally assumed to only have mild vegetative side effects, it has become evident in …

[HTML][HTML] In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center

NJ Raghunathan, J Brens, S Vemuri, QS Li… - Supportive Care in …, 2022 - Springer
Background Cannabis products, including the cannabinoids CBD and THC, are rising in
popularity and increasingly used for medical purposes. While there is some evidence that …

The long-term, prospective, therapeutic impact of cannabis on post-traumatic stress disorder

MO Bonn-Miller, M Brunstetter, A Simonian… - Cannabis and …, 2022 - liebertpub.com
Introduction: Given the increasing availability and use of cannabis among individuals with
post-traumatic stress disorder (PTSD) and the addition of PTSD as an eligible diagnosis in …